H.R. 9478 is a bill that requires the Secretary of Energy to create a research initiative focused on developing technologies aimed at removing methane, a potent greenhouse gas, from the atmosphere. The initiative would likely involve funding and support for research projects and collaborations with scientists and industry to find effective solutions for methane reduction.
The introduction of H.R. 9478 has been positively received in media outlets that focus on environmental issues, highlighting the urgent need to address methane emissions as part of broader climate change efforts. Supporters have praised the bill for its proactive approach to innovation and technology development, which could lead to significant advancements in atmospheric science and contribute to global climate goals.
Critics of H.R. 9478 have expressed concerns in various media reports regarding the feasibility and cost of developing new technologies to remove methane from the atmosphere. Some have argued that the bill may divert attention and resources away from more immediate and effective solutions for reducing methane emissions, such as regulating emissions at their source. Additionally, there are worries about the potential for technological solutions to be seen as a substitute for necessary policy changes.
The analysis of H.R. 9478 reveals no direct industry overlaps between the bill's subject matter, which focuses on methane removal technologies, and the sponsor Kevin Mullin's top donor industries. The lobbying activity related to this bill primarily involves entities such as Vertex Pharmaceuticals and various collegiate athletic conferences, which do not have a direct stake in methane reduction technologies. The total disclosed lobbying amounts in this area do not indicate a significant financial influence that could lead to a conflict of interest. Therefore, the risk of conflict is assessed as low, as the financial connections do not align with the environmental focus of the legislation.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| SANOFI U.S. SERVICES, INC. | MARSHALL & POPP, LLC | $60,000 |
| WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) | RED MAPLE CONSULTING, LLC | $40,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| SAPPHIRE DIGITAL | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Kevin Mullin, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
